REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro de Celulas Madre y Biotecnologia S.A.S. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Centro de Celulas Madre y Biotecnologia S.A.S. Profile Updated: June 11, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Centro de Celulas Madre y Biotecnologia S.A.S. is an enterprise based in Colombia. Its main office is in Pereira. It operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on January 30, 2014. 10 (2026) employees currently work for Centro de Celulas Madre y Biotecnologia S.A.S.. In 2025, the company reported a net sales revenue increase of 764.5%. Over the same period, its total assets decreased by 34.09%. The net profit margin of Centro de Celulas Madre y Biotecnologia S.A.S. decreased by 35.24% in 2025.

Headquarters
Cr 13 105 131 Av 30 de Agosto Clinica Central del Eje Lc 701
Pereira; Risaralda;

Contact Details: Purchase the Centro de Celulas Madre y Biotecnologia S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Centro de Celulas Madre y Biotecnologia S.A.S. report to view the information.
Financial Auditors:
Purchase the Centro de Celulas Madre y Biotecnologia S.A.S. report to view the information.
Incorporation Date:
January 30, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro de Celulas Madre y Biotecnologia S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
764.5%
Total Operating Revenue
764.5%
Operating Profit
-49.66%
Net Profit/Loss for the Period
-97.79%
Total Assets
-34.09%
Total Equity
-56.03%
Operating Profit Margin
-25.1%
Net Profit Margin
-35.24%
Return on Equity (ROE)
-35.65%
Quick Ratio
3.96%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?